New technique shields healthy liver during cancer radiation
Disease control
Completed
This study tested a method to protect healthy liver tissue during Yttrium-90 radioembolization, a radiation treatment for liver cancer. Doctors injected short-acting gelatin particles into arteries supplying non-cancerous liver areas to temporarily block blood flow. The goal was …
Phase: NA • Sponsor: Next Biomedical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC